<DOC>
	<DOC>NCT01040637</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics of TD-1211 in healthy subjects and activity in subjects with opioid-induced constipation (OIC).</brief_summary>
	<brief_title>A Multiple Dose Study of TD-1211 in Healthy Volunteers and Patients With Opioid-Induced Constipation</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<criteria>Males and females between 18 and 65 years of age, inclusive Healthy subjects and subjects with documented OIC on stable opioid regimen Willingness to stop all laxatives throughout the OIC screening and treatment period Any clinically significant finding in healthy subjects Have participated in another clinical trial of an investigational drug 30 days prior to screening History of chronic constipation prior to opioid therapy in OIC subjects Active medical disorders associated with diarrhea or intermittent loose stools in OIC subjects</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Healthy subjects</keyword>
</DOC>